menu
    • menu

    Company profile for Spruce Biosciences

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Spruce Biosciences is a clinical-stage biotechnology company developing novel therapies for rare endocrine disorders. Our team has extensive expertise in endocrinology and orphan drug development and our lead product candidate, Tildacerfont (SPR001), has the potential to be the first FDA-approved therapy for congenital adrenal hyperplasia (CAH), a rare endocrine disease. We are headquartered in San Francisco and have raised a ...
    Spruce Biosciences is a clinical-stage biotechnology company developing novel therapies for rare endocrine disorders. Our team has extensive expertise in endocrinology and orphan drug development and our lead product candidate, Tildacerfont (SPR001), has the potential to be the first FDA-approved therapy for congenital adrenal hyperplasia (CAH), a rare endocrine disease. We are headquartered in San Francisco and have raised a total of $28M. Or lead program, SPR001, is currently in Phase 2 clinical trials for CAH. For more information on CAH please visit our patient resources section.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Spruce BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1700 Montgomery St Suite 212 San Francisco, CA 94111
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sprucebiosciences.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Spruce Bio Appoints Keli Walbert To Board of Directors
    Spruce Bio Appoints Keli Walbert To Board of Directors

    15 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251215189566/en/Spruce-Biosciences-Appoints-Proven-Pharmaceutical-Commercial-Leader-Keli-Walbert-to-Board-of-Directors

    BUSINESSWIRE
    15 Dec 2025
    Share Share
    Spruce Bio Reveals Q3 2025 Financials And Corporate Updates
    Spruce Bio Reveals Q3 2025 Financials And Corporate Updates

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251110552861/en/Spruce-Biosciences-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Updates

    BUSINESS WIRE
    10 Nov 2025
    Share Share
    Spruce Bio Announces $50M Private Placement Financing
    Spruce Bio Announces $50M Private Placement Financing

    08 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251008435141/en/Spruce-Biosciences-Announces-%2450.0-Million-Private-Placement-Financing

    BUSINESSWIRE
    08 Oct 2025
    Share Share
    Spruce Bio Gets FDA Breakthrough Status For (TA-ERT) In MPS IIIB
    Spruce Bio Gets FDA Breakthrough Status For (TA-ERT) In MPS IIIB

    06 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251006024469/en/Spruce-Biosciences-Receives-U.S.-FDA-Breakthrough-Therapy-Designation-for-Tralesinidase-Alfa-Enzyme-Replacement-Therapy-TA-ERT-in-Sanfilippo-Syndrome-Type-B-MPS-IIIB

    BUSINESSWIRE
    06 Oct 2025
    Share Share
    Spruce Biosciences Continues Trading on Nasdaq Market
    Spruce Biosciences Continues Trading on Nasdaq Market

    15 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250915439985/en/Spruce-Biosciences-Resumes-Trading-on-the-Nasdaq-Capital-Market

    BUSINESSWIRE
    15 Sep 2025
    Share Share
    Spruce Bio Shows Durable Efficacy of TA-ERT in MPS IIIB
    Spruce Bio Shows Durable Efficacy of TA-ERT in MPS IIIB

    14 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250814678929/en/Spruce-Biosciences-Announces-Integrated-Long-Term-Clinical-Data-of-Tralesinidase-Alfa-Enzyme-Replacement-Therapy-TA-ERT-Demonstrating-Profound-and-Durable-Efficacy-and-Safety-in-Patients-with-Sanfilippo-Syndrome-Type-B-MPS-IIIB

    BUSINESSWIRE
    14 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search